Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 10526294
Pyrrolobenzodiazepines and conjugates thereof
granted -
US 10526295
Nuclear transport modulators and uses thereof
granted -
US 10526285
Therapeutic compounds and methods of use thereof
granted -
US 10525126
Modified lipopolysaccharide glycoform and method of use
granted -
US 10525290
Compositions for forming films having a desired degree of obscuration and methods of making and using the same
granted -
US 10525123
Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment
granted -
US 10525120
Methods and compositions for live attenuated viruses
granted -
US 10525248
Apparatus and method for promoting fluid uptake into an implant
granted -
US 10525068
Anti-inflammatory properties of marine lipid compositions
granted -
US 10525090
Compositions and methods for the treatment of autosomal recessive congenital ichthyosis
granted -
US 10525086
Methods for growth and maturation of ovarian follicles
granted -
US 10525053
Abuse-deterrent pharmaceutical compositions of opioids and other drugs
granted -
US 10525051
Compositions and methods for achieving sustained therapeutic drug concentrations in a subject
granted -
US 10524458
Humanized C3 animals
granted -
US 10525104
Predictive and prognostic biomarkers related to anti-angiogenic therapy of metastatic colorectal cancer
granted -
US 10526656
Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers
granted -
US 10526655
Methods for evaluating COPD status
granted -
US 10525101
Methods of treating inflammatory or autoimmune disorders with compounds that bind macrophage migration inhibitory factor
granted -
US 10526619
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10526604
Modulation of nuclear-retained RNA
granted -
CA 3103212
FORMULATIONS COMPRENANT DES INHIBITEURS DE LA DOPAMINE-S-HYDROXYLASE ET LEURS PROCEDES DE PREPARATION
granted -
US 10519467
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 10519230
Nucleic acids encoding IL-33 antibodies
granted -
US 10519153
Fused imidazo-piperidine JAK inhibitors
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.